CH

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

Retrieved on: 
Montag, November 6, 2023
Stem cell, Genetic distance, Haematopoiesis, Peripheral artery disease, Epidemiology, Smoking, Clonal hematopoiesis, Lung cancer, Genetics, Mortality, Bone marrow, Health, Carcinoma, UK Biobank, CH, Emphysema, Genome, Disease, Risk, HSC, AMGN, Gene, Chronic obstructive pulmonary disease, Gene expression, Mutation, Cardiovascular disease, Vaccine, Amgen, Nature Genetics

Clonal hematopoiesis is a condition that arises when a single clonal lineage of hematopoietic stem cells (HSC) expands and becomes the source of a substantial proportion of mature blood cells.

Key Points: 
  • Clonal hematopoiesis is a condition that arises when a single clonal lineage of hematopoietic stem cells (HSC) expands and becomes the source of a substantial proportion of mature blood cells.
  • The study reaffirmed that clonal hematopoiesis is very common in the elderly, approaching 50% in people over 80 years old.
  • Clonal hematopoiesis has many of the hallmarks of a premalignant expansion of cell clones with a potential to become cancerous.
  • Overall, the study has provided substantial insights into the genetics and epidemiology of clonal hematopoiesis.

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

Retrieved on: 
Montag, November 6, 2023
Stem cell, Genetic distance, Haematopoiesis, Peripheral artery disease, Epidemiology, Smoking, Clonal hematopoiesis, Lung cancer, Genetics, Mortality, Bone marrow, Health, Carcinoma, UK Biobank, CH, Emphysema, Genome, Disease, Risk, HSC, AMGN, Gene, Chronic obstructive pulmonary disease, Gene expression, Mutation, Cardiovascular disease, Vaccine, Amgen, Nature Genetics

Clonal hematopoiesis is a condition that arises when a single clonal lineage of hematopoietic stem cells (HSC) expands and becomes the source of a substantial proportion of mature blood cells.

Key Points: 
  • Clonal hematopoiesis is a condition that arises when a single clonal lineage of hematopoietic stem cells (HSC) expands and becomes the source of a substantial proportion of mature blood cells.
  • The study reaffirmed that clonal hematopoiesis is very common in the elderly, approaching 50% in people over 80 years old.
  • Clonal hematopoiesis has many of the hallmarks of a premalignant expansion of cell clones with a potential to become cancerous.
  • Overall, the study has provided substantial insights into the genetics and epidemiology of clonal hematopoiesis.

Even After A Marriage Falls Apart, God Is There To Comfort His Children

Retrieved on: 
Donnerstag, Oktober 26, 2023
Command General Staff College Foundation, Marriage, Divorce, Associate, Virginia Army National Guard, The, Patrick Druckenmiller, United States Department of the Army, CH, Salem Media Group, Darkness, Multimedia, Xulon Press, Command, Amazon, Love, Air force, Army, Staff Specialist Corps, NORTH, Beauty, CAS3, Bachelor of Science, Imperial Noble Consort, Tokimeki Memorial Only Love, Book, Film industry, Jewellery, Science

NORTH PORT, Fla., Oct. 26, 2023 /PRNewswire-PRWeb/ -- Author David Lee Druckenmiller shares how his Champion rescued him from a crumbled marriage in Memories of Loving You: Our Forgiven Love ($22.49, paperback, 9781662888090; $9.99, e-book, 9781662888106).

Key Points: 
  • The devil showed himself to be an evil, narcissistic predator, but God also showed Himself to be faithful and gracious.
  • He was Commissioned as an Officer and served 22 years as a Chaplain in the United States Army.
  • Xulon Press, a division of Salem Media Group, is the world's largest Christian self-publisher, with more than 20,000 titles published to date.
  • CH (LTC-R) David Lee Druckenmiller, Salem Author Services, 941-368-8410, [email protected]
    View original content to download multimedia: https://www.prweb.com/releases/even-after-a-marriage-falls-apart-god-is-...

Lonza Announces New Filling Line for Commercial Supply of Antibody-Drug Conjugates for a Dedicated Customer

Retrieved on: 
Dienstag, Oktober 17, 2023
Bioconjugation, DPS, CH, USD, CHF, CGMP, Growth, Hook effect, Spacecraft, CDMO, ADC, Fine chemical

Under the terms of the agreement, Lonza will construct a dedicated commercial-scale aseptic cGMP filling line at its Stein (CH) site.

Key Points: 
  • Under the terms of the agreement, Lonza will construct a dedicated commercial-scale aseptic cGMP filling line at its Stein (CH) site.
  • The new dedicated filling line will enable the aseptic filling of highly-potent ADCs and lyophilization under containment.
  • The additional filling capabilities further strengthen Lonza's capacity and flexibility in supporting both clinical and commercial supply of bioconjugates.
  • The additional filling line in Stein (CH) marks another milestone in the growth of Lonza’s leading Drug Product Services (DPS) offering.

CereVasc eShunt® System Study Data Presented at the European Society of Minimally Invasive Neurological Therapy (ESMINT) Congress in Marseille

Retrieved on: 
Mittwoch, September 13, 2023
Hydrocephalus, Sagrada Família, DSM-IV codes, Trial of the century, Congress, Subarachnoid hemorrhage, CH, Patient, Intracranial pressure, Pharmaceutical industry, Medical device

Trial data reporting the investigational use of the eShunt System in patients with hydrocephalus secondary to subarachnoid hemorrhage was presented by Ivan Lylyk, M.D., one of the lead investigators based at Clínica La Sagrada Familia in Buenos Aires, Argentina.

Key Points: 
  • Trial data reporting the investigational use of the eShunt System in patients with hydrocephalus secondary to subarachnoid hemorrhage was presented by Ivan Lylyk, M.D., one of the lead investigators based at Clínica La Sagrada Familia in Buenos Aires, Argentina.
  • The study, conducted under the leadership of Pedro Lylyk, M.D., represents the first-ever treatment with the eShunt System and the world's first endovascular treatment of CH.
  • "We are excited by the initial data demonstrating the potential to provide patients a minimally invasive treatment for communicating hydrocephalus.
  • The data presented at ESMINT bolster our confidence in the potential of the Company's minimally invasive treatment of hydrocephalus as we transition to the pivotal clinical trial in early 2024."

Maypharm introduces the next generation of skin booster, METOO HEALER

Retrieved on: 
Freitag, September 8, 2023
Mesotherapy, Nicotinamide, Rejuvenation, Lysine, Skin care, Biotin, Epidermis, Multimedia, Absorption, Dicarboxylic acid, Cofactor, Vitamin, Protein, CH, Histidine, B, Skin, Arginine, Dietary supplement, Online shopping

SEOUL, South Korea and NEW YORK, Sept. 8, 2023 /PRNewswire/ -- Maypharm introduces the next generation of skin booster, METOO HEALER.

Key Points: 
  • SEOUL, South Korea and NEW YORK, Sept. 8, 2023 /PRNewswire/ -- Maypharm introduces the next generation of skin booster, METOO HEALER.
  • Maypharm is a global company founded in 2015, specializing in cosmetic medicine and dermocosmetic products for skin care and rejuvenation.
  • METOO HEALER PDRN Boost CH is a premium skin revitalizing formula developed by the No.
  • Consequently, PDRN Boost CH offers antioxidant benefits and support of skin cell turnover for healthy, radiant skin.

Maypharm introduces the next generation of skin booster, METOO HEALER

Retrieved on: 
Freitag, September 8, 2023
Mesotherapy, Nicotinamide, Rejuvenation, Lysine, Skin care, Biotin, Epidermis, Absorption, Dicarboxylic acid, Cofactor, Vitamin, Protein, CH, Histidine, B, Skin, Arginine, Dietary supplement

SEOUL, South Korea and NEW YORK, Sept. 8, 2023 /PRNewswire/ -- Maypharm introduces the next generation of skin booster, METOO HEALER.

Key Points: 
  • SEOUL, South Korea and NEW YORK, Sept. 8, 2023 /PRNewswire/ -- Maypharm introduces the next generation of skin booster, METOO HEALER.
  • Maypharm is a global company founded in 2015, specializing in cosmetic medicine and dermocosmetic products for skin care and rejuvenation.
  • METOO HEALER PDRN Boost CH is a premium skin revitalizing formula developed by the No.
  • Consequently, PDRN Boost CH offers antioxidant benefits and support of skin cell turnover for healthy, radiant skin.

Story Protocol Launches With Over $54M in Funding Led by Andreessen Horowitz

Retrieved on: 
Mittwoch, September 6, 2023
Banking, Software, Entertainment, Professional Services, Internet, Blockchain, Technology, General Entertainment, Artificial Intelligence, Other Professional Services, Web3, Licensing (Entertainment), Finance, Dark, Call, Venrock, Intellectual property, Protocol, Episode, IAC, Engineering, Vader Immortal: A Star Wars VR Series, TPG Inc., Star Wars, Call of Duty, General partnership, Research, IP, Former, VR, Creativity, Black Label, Amazon, Talent, CH, Corporation, Artificial intelligence, Growth, Ecosystem, AI, CFO, SVP, Cryptocurrency, Creative industries, Film industry, Video game, TikTok, Endeavour, Media

Story Protocol is creating a new IP protocol optimized for the internet era.

Key Points: 
  • Story Protocol is creating a new IP protocol optimized for the internet era.
  • Story Protocol provides a streamlined framework to manage the entire lifecycle of IP development, enabling features like provenance tracking, frictionless licensing and revenue sharing.
  • Story Protocol presents an open and modular architecture that any application can plug into and its decentralized nature removes platform risk for ecosystem builders.
  • For more information about Story Protocol visit: https://www.storyprotocol.xyz/
    To access the media kit, please click here.

Filing eCTD (electronic Common Technical Document) Submissions Training Course: Now Mandatory for Submissions in the EU and Global regulatory Agencies

Retrieved on: 
Freitag, August 25, 2023
Maintenance, Office of Global Regulatory Operations and Policy, Maikel, Pharmacy, Common Technical Document, EMA, North West Universities Association, US, CH, Mercia, US FDA, Medical device

Mercia Lucouw works as a regulatory affairs associate at Qdossier, a Celegence company.

Key Points: 
  • Mercia Lucouw works as a regulatory affairs associate at Qdossier, a Celegence company.
  • For ten years she worked as a pharmacist in hospital and has routinely been involved in international clinical trials.
  • After joining Qdossier in 2021, she has been involved several regulatory activities covering a variety of products.
  • She is also part of the development team for DosscriberT (MS word eCTD document templates).

Codify Self-Care for Advancement of Universal Health Coverage, Says United for Self-Care Coalition at WHA76

Retrieved on: 
Donnerstag, Mai 25, 2023
FIP, Primary health care, PHC, International, Coalition, World Health Assembly, Health equity, Quality of life, International Pharmaceutical Federation, Organization, European Platform for Patients' Organisations, Science and Industry, CH, Patient, UHC, Imperial College London, GENEVE, Health, WHO, Notifiable disease, Biofeedback Certification International Alliance, World Health Organization, Nursing, Pharmaceutical industry, United

Embedding self-care practices into the healthcare continuum has the potential to improve health and quality of life whilst promoting health system sustainability.

Key Points: 
  • Embedding self-care practices into the healthcare continuum has the potential to improve health and quality of life whilst promoting health system sustainability.
  • Speakers highlighted the potential benefits of self-care, including improved health outcomes, increased access to healthcare services, stronger health systems and reduced healthcare costs.
  • "The United for Self-Care Coalition is proud to have hosted this important side event at the World Health Assembly," said Judy Stenmark, Director General of the Global Self-Care Federation.
  • For more information about the United for Self-Care Coalition and details on how to join, please visit https://www.unitedforselfcare.org